Related references
Note: Only part of the references are listed.Cell therapy for advanced liver diseases: Repair or rebuild
Benjamin J. Dwyer et al.
JOURNAL OF HEPATOLOGY (2021)
Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders
Alexandros Marios Sofias et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Molecular and cellular mechanisms of liver fibrosis and its regression
Tatiana Kisseleva et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Thomas G. Cotter et al.
GASTROENTEROLOGY (2020)
Efficient and targeted chemo-gene delivery with self-assembled fluoro-nanoparticles for liver fibrosis therapy and recurrence
Pengkai Wu et al.
BIOMATERIALS (2020)
Tailoring Nanomaterials for Targeting Tumor-Associated Macrophages
Muhammad Ovais et al.
ADVANCED MATERIALS (2019)
Non-alcoholic fatty liver disease (NAFLD) models in drug discovery
Banumathi K. Cole et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Development and dissolution studies of bisphosphonate (clodronate)-containing hydroxyapatite-polylactic acid biocomposites for slow drug delivery
Innocent J. Macha et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2017)
Attenuation of alpha-naphthylisothiocyanate (ANIT)-induced biliary fibrosis by depletion of hepatic macrophages in rats
Hossain M. Golbar et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Therapeutic Vesicular Nanoreactors with Tumor-Specific Activation and Self-Destruction for Synergistic Tumor Ablation
Junjie Li et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents
Katrin Bottcher et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis
Chun-Hung Liu et al.
MOLECULAR PHARMACEUTICS (2016)
Mechanism of hard-nanomaterial clearance by the liver
Kim M. Tsoi et al.
NATURE MATERIALS (2016)
Tailoring nanoparticle designs to target cancer based on tumor pathophysiology
Edward A. Sykes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Novel insights into the function and dynamics of extracellular matrix in liver fibrosis
Morten A. Karsdal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
被撤回的出版物: Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats (Retracted article. See vol. 22, 2022)
Cheng Liu et al.
BMC GASTROENTEROLOGY (2015)
Effect of biodegradability on CXCR4 antagonism, transfection efficacy and antimetastatic activity of polymeric Plerixafor
Jing Li et al.
BIOMATERIALS (2014)
Differential Effects of Sorafenib on Liver Versus Tumor Fibrosis Mediated by Stromal-Derived Factor 1 Alpha/C-X-C Receptor Type 4 Axis and Myeloid Differentiation Antigen-Positive Myeloid Cell Infiltration in Mice
Yunching Chen et al.
HEPATOLOGY (2014)
Nanotechnology applications for the therapy of liver fibrosis
Lydia Giannitrapani et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
PAI-1 plays a protective role in CCl4-induced hepatic fibrosis in mice: role of hepatocyte division
Claudia von Montfort et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis
Jeong Sup Song et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2010)
Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells
Ping-Fang Hu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Gene modulation for treating liver fibrosis
Kun Cheng et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2007)
Kupffer cells abrogate cholestatic liver injury in mice
S Gehring et al.
GASTROENTEROLOGY (2006)
Metal ion enhanced binding of AMD3100 to Asp262 in the CXCR4 receptor
LO Gerlach et al.
BIOCHEMISTRY (2003)
Share Paper
